APA (7th ed.) Citation

Shapiro, A. D., Kulkarni, R., Ragni, M. V., Chambost, H., Mahlangu, J., Oldenburg, J., . . . Pasi, K. J. (2023). Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B. Blood advances, 7(13), 3049-3057. https://doi.org/10.1182/bloodadvances.2022009230

Chicago Style (17th ed.) Citation

Shapiro, Amy D., et al. "Post Hoc Longitudinal Assessment of the Efficacy and Safety of Recombinant Factor IX Fc Fusion Protein in Hemophilia B." Blood Advances 7, no. 13 (2023): 3049-3057. https://doi.org/10.1182/bloodadvances.2022009230.

MLA (9th ed.) Citation

Shapiro, Amy D., et al. "Post Hoc Longitudinal Assessment of the Efficacy and Safety of Recombinant Factor IX Fc Fusion Protein in Hemophilia B." Blood Advances, vol. 7, no. 13, 2023, pp. 3049-3057, https://doi.org/10.1182/bloodadvances.2022009230.